Studies have shown that vitamin D could have a role in breast cancer survival; however, the evidence of the relationship between patients' vitamin D levels and their survival has been inconsistent. This meta-analysis explores possible dose-response relationships between vitamin D levels and overall survival by allowing for differences in vitamin D levels among populations of the various studies.
6 studies with a total number of 5984 patients were identified. At or above a 23.3 nmol/L threshold, for a 10 nmol/L, 20 nmol/L, or 25 nmol/L increment in circulating 25-OH-D levels, the risk of breast cancer overall mortality decreased by 6%, 12%, and 14%, respectively.
These findings suggest that there is a highly significant linear dose-response relationship between circulating 25-OH-D levels and overall survival in patients with breast cancer.
The informations and advices published or made available through drsuciu.com web site are not intended to replace the services of a physician, or any other therapist nor does it constitute a doctor-patient relationship.
You should not use the information on this website for diagnosing or treating a medical condition or a health problem
We advise you to consult your doctor regarding all matters relating to your health and in particular regarding the existence of symptoms that may require diagnosis or medical care